India Trials Scenario: Leaders From Novartis, IQVIA, PwC Signal Winds Of Change

 
• By Anju Ghangurde

Leaders from Novartis, IQVIA and PwC discuss the ground situation for trials in India as regulatory reforms, improved infrastructure and clinical expertise provide opportunities. Potential in areas like orphan diseases and tips for peer Amgen on getting trials going in India were among other highlights.

India's clinical trials segment provides opportunities • Source: Shutterstock

More from R&D

More from Scrip